Abbrea Capital LLC cut its stake in MetLife, Inc. (NYSE:MET – Get Rating) by 4.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,892 shares of the financial services provider’s stock after selling 220 shares during the quarter. Abbrea Capital LLC’s holdings in MetLife were worth $306,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Ingalls & Snyder LLC acquired a new stake in shares of MetLife during the 3rd quarter worth about $205,000. WINTON GROUP Ltd increased its position in shares of MetLife by 76.1% during the 3rd quarter. WINTON GROUP Ltd now owns 14,758 shares of the financial services provider’s stock worth $911,000 after purchasing an additional 6,376 shares during the last quarter. Community Bank N.A. increased its position in shares of MetLife by 300.0% during the 3rd quarter. Community Bank N.A. now owns 800 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 600 shares during the last quarter. Intrua Financial LLC increased its position in shares of MetLife by 13.2% during the 3rd quarter. Intrua Financial LLC now owns 6,002 shares of the financial services provider’s stock worth $386,000 after purchasing an additional 701 shares during the last quarter. Finally, 180 Wealth Advisors LLC increased its position in shares of MetLife by 2.4% during the 3rd quarter. 180 Wealth Advisors LLC now owns 25,906 shares of the financial services provider’s stock worth $1,699,000 after purchasing an additional 619 shares during the last quarter. 88.85% of the stock is owned by institutional investors and hedge funds.
MET stock traded up $0.70 during trading on Monday, hitting $71.34. 123,297 shares of the company’s stock were exchanged, compared to its average volume of 4,700,582. The business has a 50-day moving average price of $68.64 and a two-hundred day moving average price of $65.58. The stock has a market capitalization of $58.86 billion, a price-to-earnings ratio of 9.67, a PEG ratio of 1.33 and a beta of 1.18. MetLife, Inc. has a 52-week low of $55.21 and a 52-week high of $72.55. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.22.
In other MetLife news, EVP Steven J. Goulart sold 56,857 shares of MetLife stock in a transaction that occurred on Tuesday, February 8th. The stock was sold at an average price of $70.29, for a total transaction of $3,996,478.53. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.20% of the company’s stock.
A number of equities analysts recently commented on the company. Evercore ISI upgraded MetLife from an “in-line” rating to an “outperform” rating and raised their target price for the company from $67.00 to $75.00 in a report on Wednesday, January 5th. JPMorgan Chase & Co. raised their target price on MetLife from $69.00 to $75.00 in a report on Tuesday, April 5th. Jefferies Financial Group assumed coverage on MetLife in a report on Tuesday, January 25th. They set a “buy” rating and a $74.00 target price for the company. Wells Fargo & Company lowered their target price on MetLife from $75.00 to $74.00 and set an “overweight” rating for the company in a report on Tuesday, January 4th. Finally, Piper Sandler raised their target price on MetLife from $77.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, April 6th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $74.14.
MetLife Company Profile (Get Rating)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
- Get a free copy of the StockNews.com research report on MetLife (MET)
- Banking On Bank Of America
- Major Shareholder Bets Big On Nielson Holdings plc
- Tapestry Stock is a Value Play Down Here
- Levi Straus Stock Ready to Buy the Dip
- Bed Bath & Beyond Stock Ready to Scale Into
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.